postapproval marketing

Pharma

Sanofi, GSK, Pfizer and BI can't escape Zantac suits, court says

Even after the global Zantac recalls and the associated controversy, the courtroom saga over the medicine's risk is just getting started.
Eric Sagonowsky Oct 8, 2021 10:55am

Biogen reps banned from neurology clinics over Aduhelm fallout

Sep 22, 2021 6:44pm

Biogen's latest Alzheimer's ad provokes fresh concerns

Jul 27, 2021 2:18pm

Nabriva scores its first FDA nod with novel antibiotic Xenleta

Aug 19, 2019 12:26pm

Acadia readies new round of Nuplazid DTC

Aug 4, 2019 10:48am

Does a $400M-plus cash raise put Amarin buyout out of reach?

Jul 22, 2019 11:45am